These represented cell cycle/mitosis; among others CCNE1, CCNE2, CCNG2, CCNL1, CCNT1, CDK12 and CDKN3, prostate cancer; including the androgen receptor (AR), metabolism as well as targets of the transcription factors E2F, AP2, SP1, ETF and Pax3. Here, TEAD2 is linked to prostate carcinoma.